Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like Reliance Jio Prime forces telecom firms to focus on high-paying customers March 2, 2017 Leuze electronic introduces CMS 700i 3D contour measurement system November 16, 2019 Mitsubishi Electric announces slice type I/O modules August 21, 2019